Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Preoperative FOLFIRINOX For Potentially Curable Pancreatic Cancer

NCT03167112 is registered in ClinicalTrials.gov with Petr Kavan as lead sponsor.

NCT NCT03167112
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03167112 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Preoperative FOLFIRINOX For Potentially Curable Pancreatic Cancer
Lead sponsor
Petr Kavan
Phase
Phase 2
Overall status
Unknown status
Start date
July 3, 2017
Completion date
May 31, 2018
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer